04.10.2017 21:57:16
|
CytomX Therapeutics Holding On To Strong Gain In Late-Day Trading
(RTTNews) - Shares of CytomX Therapeutics (CTMX) have pulled back off their highs of the session but continue to significant strength in late-day trading on Wednesday. After reaching its best intraday level in well over a year, CytomX is currently up by 20.5 percent.
The jump by CytomX comes after the biopharmaceutical company announced it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CytomXmehr Nachrichten
06.11.24 |
Ausblick: CytomX präsentiert Quartalsergebnisse (finanzen.net) |
Analysen zu CytomXmehr Analysen
Aktien in diesem Artikel
CytomX | 0,78 | 0,91% |
|